Integrated Diagnostics (IDHC) Competitors

Diaceutics (LON:DXRX) and Integrated Diagnostics (LON:IDHC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, community ranking, risk, analyst recommendations, institutional ownership, valuation and earnings.

Do institutionals and insiders believe in DXRX or IDHC?

52.4% of Diaceutics shares are held by institutional investors. Comparatively, 43.0% of Integrated Diagnostics shares are held by institutional investors. 34.3% of Diaceutics shares are held by insiders. Comparatively, 34.0% of Integrated Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has more risk & volatility, DXRX or IDHC?

Diaceutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Integrated Diagnostics has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Does the media refer more to DXRX or IDHC?

In the previous week, Diaceutics had 2 more articles in the media than Integrated Diagnostics. MarketBeat recorded 3 mentions for Diaceutics and 1 mentions for Integrated Diagnostics. Integrated Diagnostics' average media sentiment score of 0.67 beat Diaceutics' score of 0.03 indicating that Integrated Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Diaceutics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integrated Diagnostics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate DXRX or IDHC?

Diaceutics presently has a consensus target price of GBX 160, indicating a potential upside of 14.29%. Given Diaceutics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Diaceutics is more favorable than Integrated Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Integrated Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has preferable earnings & valuation, DXRX or IDHC?

Integrated Diagnostics has higher revenue and earnings than Diaceutics. Diaceutics is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diaceutics	£26.08M	4.53	-£2.84M	-£3.37	-41.52
Integrated Diagnostics	£23.29T	0.00	£4.01T	£0.03	13.31

Is DXRX or IDHC more profitable?

Integrated Diagnostics has a net margin of 17.21% compared to Diaceutics' net margin of -10.90%. Integrated Diagnostics' return on equity of 30.45% beat Diaceutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diaceutics	-10.90%	-7.15%	-6.06%
Integrated Diagnostics	17.21%	30.45%	9.69%

Does the MarketBeat Community favor DXRX or IDHC?

Integrated Diagnostics received 41 more outperform votes than Diaceutics when rated by MarketBeat users. However, 88.24% of users gave Diaceutics an outperform vote while only 65.12% of users gave Integrated Diagnostics an outperform vote.

Company	Underperform	Outperform
Diaceutics	Outperform Votes 15 88.24%	Underperform Votes 2 11.76%
Integrated Diagnostics	Outperform Votes 56 65.12%	Underperform Votes 30 34.88%

Summary

Integrated Diagnostics beats Diaceutics on 10 of the 18 factors compared between the two stocks.